“The Applicant evaluated the toxicity profile of capmatinib in GLP-compliant studies in Sprague-Dawley rats and Cynomolgus monkeys with durations of treatment of up to 13 weeks.”
✓ VerifiedFDA multi-discipline review, p. 32Source ↗
Why that species
Historical use in safety testing and highly conserved MET receptor sequence
“The rat and monkey were selected as the rodent and non-rodent species, respectively, for repeat-dose toxicity testing because both have historically been used in safety evaluations, and both species have a highly conserved MET receptor target protein sequence.”
“The Applicant evaluated the toxicity profile of capmatinib in GLP-compliant studies in Sprague-Dawley rats and Cynomolgus monkeys with durations of treatment of up to 13 weeks.”
✓ VerifiedFDA multi-discipline review, p. 32Source ↗